NCT04779554 2026-04-01
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
Phase 2 Recruiting
Clinical Trials
9 trialsNCT01815359 2026-02-05
ICARuS
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT02040142 2024-10-24
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Phase 2 Completed
NCT03073694 2023-06-09
Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis
University of Kansas Medical Center
Phase 2 Unknown
NCT04845490 2022-02-21
WUHIPEC02
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Not yet recruiting
NCT00005944 2021-02-17
Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
UNICANCER
Phase 2 Terminated
NCT00271011 2015-12-03
A Study of Mitomycin C, Irinotecan, and Cetuximab
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT00006112 2011-04-26
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00454519 2009-02-13
IPHC
Wuhan University
Phase 2 Unknown